Bearish
Court rules CINVANTI patents invalid; Heron readies appeal
A U.S. District Court has ruled two of Heron Therapeutics' CINVANTI patents invalid in a dispute with Azurity. Heron Therapeutics (HRTX) announced its...
HRTX
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (1)
Latest HRTX News
Bearish
Neutral
U.S. District Court Issues Decision Regarding CINVANTI® Patents
Heron Therapeutics announced that the U.S. District Court for the District of Delaware ruled its CINVANTI® patents invalid in a dispute with Azurity P...
Research HRTX on:
Ad Space